Non-physician Prescribers and Pharmaceutical Industry Interactions

Reducing the Impact of Pharmaceutical Marketing to Physicians and Promoting Appropriate Prescribing and Drug Safety

Non-physician Prescribers and Pharmaceutical Industry Interactions

Nurse Practitioners and Physician Assistants are authorized to prescribe medications in all fifty states and the District of Columbia, with varying limits for physician counter-signing and controlled substances. Industry marketing to NPs and PAs has increased markedly in recent years to roughly 20 million detail visits in 2006, a 20% increase over 2004. The 86% of physician assistants who see pharmaceutical sales reps on a weekly basis have an average of 6.8 detailer interactions each week. Pharmacists have some prescribing authority in at least 25 states.

Download the full PDF for more information.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.